previous compound ID: 383 next compound
InChIKey: CTRLABGOLIVAIY-UHFFFAOYSA-N
SMILES: C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "B Kus" "DY Thomas" "JW Hanrahan" "E Matthes" "J Liao" "SD Macknight" "GW Carlile" "D Rotin" "R Robert"

chemical graph of compound 383





CID is 34312
synonyms found at PubChem are:
OXCARBAZEPINE, Trileptal, 28721-07-5, Oxcarbamazepine, Oxacarbazepine, Oxcarbazepina, Oxcarbazepinum, Timox, KIN-493, GP 47680, GP-47680, Oxcarbazepinum [INN-Latin], Oxcarbazepina [INN-Spanish], Oxcarbazepine [INN], Oxcarbazepime, Epilexter, Epliga, 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, Trileptal (TN), UNII-VZI5B1W380, 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide, 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide, 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide, MLS000084586, EINECS 249-188-8, CHEMBL1068, SMR000048684, CHEBI:7824, VZI5B1W380, 5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo-, 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-oxo-, SPN-804, CTRLABGOLIVAIY-UHFFFAOYSA-N, NCGC00065934-02, O0363, 9-oxo-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide, DSSTox_CID_25703, DSSTox_RID_81075, DSSTox_GSID_45703, W-107033, 10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide, 10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide, Oxtellar XR, CAS-28721-07-5, SR-01000612612, oxecarb, Oxcarbazepin, Oxcarbazepine-d4, HSDB 7524, Oxaleptal (TN), Oxtellar (TN), Oxcarbazepine [USAN:USP:INN:BAN], OCBZ, Spectrum_001675, Opera_ID_818, AC1L1RCU, regid866068, Spectrum2_000483, Spectrum3_001669, Spectrum4_000634, Spectrum5_001869, D0QL3P, AC1Q6NA8, Oxcarbazepine (USAN/INN), SCHEMBL35129, BSPBio_003457, KBioGR_001248, KBioSS_002155, cid_34312, MLS000759520, MLS001201742, MLS001424025, MLS006011855, BIDD:GT0078, Desitin brand of oxcarbazepine, SPECTRUM1504243, SPBio_000345, Novartis brand of oxcarbazepine, GTPL7254, ZINC4724, DTXSID0045703, Oxcarbazepine (JAN/USAN/INN), BDBM34179, KBio2_002155, KBio2_004723, KBio2_007291, KBio3_002677, MolPort-001-685-316, Oxcarbazepine, analytical standard, HMS1922H17, HMS2051O04, HMS2090F13, HMS2093E10, HMS2231B12, HMS3369J22, HMS3393O04, HMS3657O11, HMS3713I10, Pharmakon1600-01504243, BB_SC-01874, BCP28260, HY-B0114, Tox21_110983, BBL010789, BG0593, CCG-39509, MFCD00865307, NSC758693, s1391, STK594696, AKOS005516529, Tox21_110983_1, AC-3483, AN-6739, API0003702, CS-1869, DB00776, KS-5197, MCULE-9100100302, NC00088, NSC-758693, Oxcarbazepine, >=98% (HPLC), solid, NCGC00065934-03, NCGC00065934-04, NCGC00065934-05, NCGC00065934-06, BC204104, CC-33410, CPD000048684, LS-60365, SAM001246754, SC-16252, ZB000586, SBI-0206772.P001, AB0012847, AB1004555, AM20040094, FT-0630543, C07492, D00533, EN300-123538, J10384, W-2542, AB00393017-12, AB00393017-14, AB00393017_15, AB00393017_16, 721O075, C-15585, I06-0072, SR-01000612612-4, SR-01000612612-6, BRD-K04196797-001-12-9, 10-oxo-10,11-dihydro-5H-dibenz(b,f)azepin-5-carboxamide, 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine, 10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carbonsaeureamid, 10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide #, Oxcarbazepine, European Pharmacopoeia (EP) Reference Standard, 10,11-Dihydro-10-oxo-5H-dibenzo(Z)[b,f]azepine-5-carboxamide, Oxcarbazepine, United States Pharmacopeia (USP) Reference Standard, 10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide; Oxacarbazepine, Oxcarbazepine, Pharmaceutical Secondary Standard; Certified Reference Material, 9-oxo-2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide, Oxcarbazepine-13C6 solution, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material